Editorial Policy - dLife.com - For Your Diabetes Life
Last updated: January 13, 2011
dLife strives to harness the power of mass media and bring the most objective, trustworthy, accurate, inspiring health and lifestyle information to the diabetes community that enables better patient self-management.
dLife attempts to provide general but comprehensive coverage of all disciplines of interest and reflects the interdisciplinary of modern scientific research, lifestyle, and self-management findings as it relates to diabetes.
dLife reviews and monitors material covered on an ongoing and systematic basis, in order to ensure that it continues to provide the most up-to-date and accurate information.
The guidepost for dLife is our Editorial Policy, drawn from the editorial policies and guidelines of the most recognized names in medicine and journalism: The American Medical Association, the Society of Professional Journalists, and the American Medical Writers Association. In following these guidelines, the dLife editorial staff diligently seeks the facts and reports them, providing thorough and honest coverage of health and medicine and, most of all, upholding the highest professional standards in the industry.
All electronic, printed, and broadcast material provided by dLife is for informational purposes only, and should never be used as a substitute for a consultation with a professional healthcare provider. The audience should always discuss any information found through dLife with their healthcare professional, who can provide treatment recommendations and individualized medical care.
All materials selected are evaluated according to certain criteria that form the core guiding principles of dLife selection policy:
• dLife maintains coverage of journal titles, announcements from federal health agencies, and analyses on the latest health trends considered central to the study of diabetes and diabetes self-management.
• While the traditional focus of dLife is diabetes, it also includes supportive and complementary disciplines such as lifestyle, exercise and fitness, self-management, nutrition, and medical conditions related to diabetes (i.e., diabetic complications).
• The dLife Medical Advisory Board is comprised of leaders in the field of diabetes care. The Board provides content direction and review oversight on an as-needed basis.
• Journals and studies utilized are of a scholarly nature and contain clinical and analytical articles that are ideally peer reviewed by an editorial board containing respected academics. dLife will also cover credible newspapers, magazines, reports, information bulletins, statistical reports, medical conferences, federal or state government actions, and enterprise material derived from interviews with medical experts. The majority of stories originate from studies published in peer-reviewed medical journals.
• dLife content references clinical guidelines and standards that are widely accepted by the diabetes medical community, including the annual American Diabetes Association (ADA) Clinical Practice Guidelines and the American Association of Clinical Endocrinologists (AACE) Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus.
• dLife also believes that valuable content is available from dLife sponsors, advertisers, and partners, but that such content must be clearly labeled as such.
The dLife editorial staff works to ensure that the editorial remains current and relevant to the needs of audience as a whole. The dLife editorial staff, based on the guiding principles, undertakes regular editorial coverage reviews. dLife editorial is free from influence by sponsors, partners, or other sources. The dLife editorial staff is charged with the responsibility of providing objective, accurate, and balanced accounts of events and issues. dLife’s editorial staff is separate and distinct from staff dedicated to sponsors or partners.
dLife employs a team of experienced freelance medical journalists and professionals to create certain content on dLife.com. This content is subject to the same editorial review and oversight as internally-created content.
Anyone who serves on the dLife editorial staff or who provides editorial content to dLife.com must fully disclose any financial or other interests that he or she may have in any drug, biotech, medical device, or other company perceived to have influence in the healthcare industry. Such disclosure must be made to the individual's immediate supervisor at the time of hiring or at the time that the financial or other interest develops. The supervisor will determine whether the interest presents a conflict and, if so, what must be done to eliminate it.
Each completed story to be published is reviewed by a medical editor for accuracy, appropriateness of medical language, and proper characterization of the findings. The story is then edited for style, flow, grammar, and readability.
When dLife licenses health and wellness content from third parties for publication the dLife senior medical editors and physician editors review the third-party's editorial policies and procedures for consistency with the dLife Editorial Policy, including without limitation the conflicts of interest policy.
Sponsored Content and Advertising
dLife would prefer not to display advertising banners. However, in order to keep our website free for our users, we must derive enough revenue to cover operating costs. Advertising is the main way we can generate this revenue. We apologize for any inconvenience that these advertisements may cause.
dLife will include editorial/advertising content from its sponsors. This content will be labeled "Sponsored," "From Our Sponsor," or "Advertisement." This content has not been reviewed by the dLife editorial staff and is not subject to this Editorial Policy.
dLife has sought sponsorships from trusted and credible research organizations, manufacturers, and other leaders dedicated to treating and managing diabetes. Although there is a commercial benefit for dLife, sponsor information also benefits the dLife audience by providing them with the most up-to-date information on medications, medical devices, health services, and therapies in the marketplace.
Sponsored content has been either provided by or influenced by the named sponsor. While sponsored content is subject to dLife's Advertising Policy, it is not reviewed by the dLife editorial staff. Therefore, we take meaningful steps to ensure that our users will not confuse sponsored content with dLife editorial content.
dLife Advertising Policy
Fresh Spinach Salad Pork Dumpling Soup Holiday Appetizer Wreath Sauteed Kale with Spicy Tomatoes Toasted Corn Salad With Citrus Vinaigrette Oatmeal - Pecan Cookies Chicken Salad Sandwiches with Apples Nectarine and Prosciutto Salad Cheesy Apple Crunch Mini Cheeseburgers
Unlike most of the working world, my employer has set our benefits year to start and end with the fiscal year (July 1 to June 30), meaning that we're heading into that season where we must select, among other things, our healthcare benefits. One of my issues with the options we've had through the current benefits year has been that of handling our high-deductible plan with a token employer contribution to a Health Reimbursement Account (HRA) that automatically depletes before we...